ARCHIVES

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

Cancer, AIDS Patient Advocates List Drug Development Concerns

May 12, 1989

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

DCPC Advisors Okay New Grant Programs To Improve Participation Of Women, Minorities In Clinical Trials

May 26, 1995